Sherry Korczynski
Chief Commercial Officer · Aquestive Therapeutics, Inc.
- 2025
- Sep 11, 2026
- 6
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Sherry Korczynski files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Daniel Barber - $1.22M in AQST purchases and sales in the last 12 months
- Cassie Jung - $665K in AQST purchases and sales in the last 12 months
- A. Ernest Toth Jr. - $243K in AQST purchases and sales in the last 12 months
- Peter E. Boyd - $194K in AQST purchases and sales in the last 12 months
- Lori J. Braender - $167K in AQST purchases and sales in the last 12 months
- Carl N. Kraus - $142K in AQST purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Sherry Korczynski?
Sherry Korczynski is a corporate insider, tracked as Chief Commercial Officer of Aquestive Therapeutics, Inc. (AQST). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Sherry Korczynski submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Sherry Korczynski been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($111K) across all tracked filings.
